The crosstalk between the free fatty acid receptor FFA4 and the lysophosphatidic acid receptor LPA 1 seems to be of pathophysiological importance. We explored this crosstalk employing co-expression of fluorescent protein-tagged receptors. FFA4 activation induces functional desensitization of LPA 1 receptors and phosphorylation of both receptors. LPA 1 activation induces phosphorylation of LPA 1 , but not of FFA4, and induces internalization of both receptors into heterogeneous types of vesicles. Docosahexaenoic acid (DHA) induces internalization of FFA4 but not of LPA 1 . Fatty acid-induced FFA4-LPA 1 interaction was observed using F€ orster resonance energy transfer and co-immunoprecipitation. Such interaction took place after desensitization was already established. Data indicate that FFA4 activation induces LPA 1 desensitization in an internalization-independent process and that complex cellular processes participate in the crosstalk of these receptors.
Long chain fatty acids are well-known nutrients and metabolic substrates precursors for the biosynthesis of other lipids, and are important energy sources. These fatty acids also exert a wide variety of effects, many of these, receptor-mediated, and for this reason they are considered among the so-called, bioactive lipids. Some of these actions are mediated through activation of nuclear receptors/transcription factors [1] , ion channels [2] , and G protein-coupled receptors (GPCRs) [3, 4] . Free fatty acid receptor 4 (FFA4) (previously known as GPR120) [5] is one of the main GPCR targets of long chain fatty acids and has received considerable attention in recent years, due to its physiological roles [5, 6] and its potential as a therapeutic target [7, 8] .
FFA4 is an intestinal nutrient-sensor whose activation induces gut incretin (glucagon-like peptide-1) release, which modulates glycemia through pancreatic insulin secretion [5] . In addition, FFA4-activation induces insulin-sensitizing and anti-inflammatory effects in isolated cells (adipocytes and macrophages) and whole animals (mice) [9] . Consistent with this, it has been observed that FFA4-deficient mice develop obesity, glucose intolerance, and fatty liver, and that a dysfunctional FFA4 variant (R270H) is associated with obesity and other metabolic disturbances in humans [6] .
Lysophosphatidic acid (LPA) is another important bioactive lipid and one of the main mitogenic compounds of blood serum [10] . It is considered a survival Abbreviations DHA, docosahexaenoic acid; DMEM, Dulbecco's modified Eagle's medium; eGFP, enhanced green fluorescent protein; ERK 1/2, extracellular signal-regulated kinases; FRET, F€ orster resonance energy transfer; GPCRs, G protein-coupled receptors; LPA, lysophosphatidic acid; mCherry, Discosoma sp. red fluorescent protein (DsRed) variant.
factor [11] , it is involved in many physiological functions and in the pathogenesis of several diseases [12] [13] [14] , particularly those related to cancer [12, [15] [16] [17] . LPA exerts its actions through the activation of a family of 6 GPCRs, called LPA [1] [2] [3] [4] [5] [6] . [17] . LPA 1 couples mainly to Gi proteins, although it can exert some of its actions through Gq or G12/13 [17] . LPA 1 exhibits ubiquitous expression and in some organs, such as lung, gut and prostate, among others, there is co-expression with FFA4. Particularly, in prostate cancer cells it has been shown that LPA induces cell proliferation [18] and that FFA4 activation leads to blockade of LPA actions, through inhibition of LPA 1 signaling [19] [20] [21] .
There is a wide range of examples of crosstalk among membrane receptors and one of the possible consequences of this is desensitization, in many cases associated with receptor phosphorylation and internalization [22] . These processes have been shown for LPA 1 receptors [19] [20] [21] [23] [24] [25] [26] . Another interesting event that can take place with GPCRs is their homo and heterodimerization [27, 28] . GPCRs may exist as dimers under baseline conditions and the monomer/dimer balance can be modulated positively or negatively by their ligands [27, 28] . It has also been observed that dimer formation might exert profound influences in the pharmacological profile of the receptors, their signaling, regulation, and cellular localization [27, 28] .
Even though we know that there is negative crosstalk between FFA4 and LPA 1 [19] [20] [21] , and several possibilities were recently proposed [29] , the mechanisms through which this heterologous desensitization occurs remain unknown. We explored the possible mechanisms involved, through different experimental approaches using FFA4-mCherry (Discosoma spp. red fluorescent protein [DsRed] variant) and LPA 1 -eGFP (enhanced Green Fluorescent Protein) receptor constructs expressed in HEK 293 cells. Our results indicate that FFA4 activation induced functional desensitization of LPA 1 receptors involving receptor phosphorylation and agonist-induced FFA4-LPA 1 interaction without triggering LPA 1 internalization. Our results provide insight into the cellular processes involved in this heterologous desensitization process.
Material and methods

Materials
Plasmids for the expression of human LPA 1 receptors tagged to eGFP (product ID Z7377-M98) and human FFA4 short form receptors [30] 
Cells and transfection
HEK 293 cells (American Type Culture Collection, Manassas, VA, USA) were cultured as described [33] . These cells do not appear to express functional free fatty acid receptors [5, 30] but do express LPA 1 receptors [35] . To study FFA4-mCherry and LPA 1 -eGFP interaction, plasmids for the expression of these tagged receptors were co-transfected (FFA4-mCherry, 3 lg and LPA 1 -eGFP, 9 lg for a 10-cm diameter Petri dish,~90% cell confluence) employing polyethyleneimine [36] ; experiments were carried out 48 h posttransfection. These conditions were defined in preliminary experiments; plasmid expression was confirmed using fluorescence microscopy.
Intracellular free calcium concentration
This was determined fluorometrically as described previously [31] . Briefly, cells were loaded with 2.5 lM Fura-2 AM and then washed to eliminate unincorporated indicator. Determinations were carried out in an AMINCO-Bowman Series 2 luminescence spectrometer (Rochester, NY, USA), employing 340-and 380-nm excitation wavelengths and an emission wavelength of 510 nm; chopper interval was 0.5 s. Intracellular calcium concentration was calculated as described by Grynkiewicz et al. [37] .
ERK 1/2 phosphorylation
Cells were incubated as indicated, and cellular extracts were obtained by lysing the cells in detergent, protease, and phosphatase inhibitors-containing buffer [31] . Cell extracts were added to 29 Laemmli 0 s sample buffer [38] and subjected to 10% SDS/PAGE and transferred onto nitrocellulose membranes. Samples were incubated overnight at 4°C, with antiphospho-ERK 1/2; the following day, membranes were washed and incubated for 1 h at room temperature with a horseradish peroxidase-conjugated secondary antibody for enhanced chemiluminiscence detection. Afterward, the same membranes were reprobed using anti-ERK 1/2 (total) primary antibody, as a loading control. Densitometric analysis was performed using IMAGEJ software (http://rsb.info.nih. gov/ij/) [39] . Data are presented as percentage of baseline value taking into account loading (total ERK 1/2).
FFA4 and LPA 1 phosphorylation
The procedure previously described was used [31] and modified to study both receptors in the same sample. In brief, cells were incubated in phosphate-free DMEM containing 100 lCiÁmL À1 [
32 P]Pi for 3 h a 37°C. Labeled cells were stimulated with DHA or LPA and then washed twice with ice-cold phosphate buffered saline solution and solubilized in 1 mL of detergent-and protease and phosphatase inhibitor-containing buffer [31] . Two equal aliquots of the lysates (~450 lL each) were incubated overnight with protein Aagarose and either anti-eGFP or anti-DsRed serum, with constant agitation at 4°C. Samples were washed and the pellets were solubilized in Laemmli's sample buffer containing 130 mM dithiothreitol. Proteins were separated using 10% SDS/PAGE and electrotransferred onto nitrocellulose membranes. Receptor phosphorylation was analyzed with a MOLECULAR DYNAMICS TYPHOON PHOSPHORIMAGER and the IM-AGEQUANT software (General Electric-Amersham Health, Port Washington, NY, USA). The same membranes were processed for detection of the receptors (eGFP or mCherry) by Western blot and were then scanned and quantified. The data were used for normalization which did not alter the patterns observed.
Confocal fluorescence microscopy
To study receptor internalization, cells were seeded at 60% confluence onto glass-bottomed Petri dishes coated with poly-D-lysine and cultured for 24 h at 37°C in media containing 10% serum and further incubated for additional 3 h in media without serum. Cells were stimulated with DHA or LPA for the times indicated and were then washed with PBS, fixed with 4% paraformaldehyde in 0.1 M phosphate buffer for 30 min at room temperature and then washed five times with PBS. Images of 5-6 independent experiments using different cell cultures were obtained employing a mW], 559 nm) with a waterimmersion objective (609). The eGFP was excited at 489 nm and the emitted fluorescence was detected at 510 nm, while the red fluorescent protein, mCherry, was excited at 580 nm and the fluorescence emitted was detected at 610 nm. To determine receptor internalization, total fluorescence was determined and then the plasma membrane was delineated using the differential interference contrast image, this fluorescence was excluded, and the intracellular fluorescence was quantified employing IMAGEJ software. The fluorescence ratio (intracellular/ total) was obtained and values at time 0 0 (baseline) were considered as 100%.
F€ orster resonance energy transfer (FRET)
Interaction between FFA4 and LPA 1 receptors was analyzed using FRET by means of the sensitized-emission method, employing a confocal microscope equipped with an automated laser spectral scan FV10i Olympus, as described [32] , with minor modifications. Expression of eGFP-and mCherry-tagged proteins was confirmed for each experiment. Excitation and emission wavelengths for eGFP and mCherry were those indicated previously. For FRET channel analysis, eGFP (but not mCherry) was excited and fluorescence was detected at 610 nm. The same images obtained to quantify receptor internalization were used. The FRET index (that eliminates 'bleed-through' and 'false' FRET) was quantified using IMAGEJ software and the 'FRET and Colocalization Analyzer' plug-in [40] . This plug-in functions with 8-bit images and allows supervised computation of the FRET index by means of a 'pixel-by-pixel' method.
Co-immunoprecipitation and western blot assays
The cells were incubated with DHA for the times indicated and then washed and lysed as previously described for the receptor phosphorylation experiments. Immunoprecipitation was performed using anti-DsRed antiserum. The samples were subjected to 10% SDS/PAGE and the proteins were electrotransferred onto nitrocellulose membranes for immunoblotting. Primary antibodies (monoclonal antieGFP antibodies or anti-DsRed antiserum) 3 h at 4°C and with secondary antibodies for 1 h at room temperature. Chemiluminescence kits were used to expose the membranes to X-Omat X-ray film and densitometric quantification was performed using IMAGEJ software [39] .
Statistics
Statistical comparison between two groups was performed using the Student t test; when three or more groups were compared analysis of variance with Bonferroni's post-test was used, employing the software included in the GRAPHPAD PRISM 6 program (La Jolla, CA, USA). A P value < 0.05 was considered statistically significant.
Results and Discussion
The effect of the natural agonists LPA (1 lM) and DHA (30 lM), on intracellular calcium concentration, were tested in HEK 293 cells co-expressing LPA 1 -GFP and FFA4-mCherry receptors. These near-saturating concentrations were selected on the basis of previous studies [26, 31, 34, 41, 42] and the initial work with these cells. As shown in Fig. 1 (panels A, B and F) DHA induced a~2-fold increase in calcium concentration whereas the LPA effect was considerably larger in maximal and the peak was sharper. Figure 1 also presents calcium tracings showing that DHA-stimulated cells no longer respond to LPA, whereas LPA-stimulated cells clearly respond to DHA; i. e., DHA induced a very rapid LPA 1 desensitization. However, thapsigargin, an inhibitor of the sarcoplasmic reticulum Ca 2+ -ATPase, was able to increase intracellular calcium, indicating that depletion of the cation stores was not responsible for the absence of response (Fig. 1, panel E) . These data are in agreement with the previous publications of Meier and coworkers, who observed that FFA4 activation blocks LPA 1 -mediated migration and proliferation, using breast and prostate cancer cells that endogenously express these receptors [19] [20] [21] . We also observed that DHA-stimulation blocked the increase of the intracellular calcium concentration induced by other agents, such as carbachol, ATP or sphingosine 1-phosphate; the mechanisms involved were not further explored. Hopkins et al. [20] observed that free fatty acids blocked LPA-induced proliferation and also partially inhibited the EGFinduced effect; this latter action appears to involve crosstalk with LPA 1 . The FFA4 antagonist/ negative allosteric modulator, AH7614 [34, 43, 44] , was used to confirm that DHA-induced LPA 1 desensitization was indeed mediated through FFA4 receptors and was not due to any other effect. Preincubation with 30 lM AH7614 essentially abolished the response to DHA, indicating that the intracellular calcium increase induced by DHA is mediated by FFA4. In addition, after the lack of response to DHA, cells were capable of responding to LPA, indicating that LPA 1 desensitization induced by DHA is FFA4-mediated (Fig. 1 , panels C and F). Similarly, when cells were stimulated with DHA for 2 min and then washed with buffer containing defatted albumin to remove the fatty acid, a calcium response to LPA was observed (Fig. 1 , panels D and F), showing that FFA4 desensitization was reversible.
In additional experiments, we tested the effect of the synthetic FFA agonist, TUG-891. The effects of TUG-891 were very similar to those induced by DHA; i.e., (a) TUG-891 induced a strong calcium response that blocked the action of LPA, (b) these two actions of the synthetic agonist were blocked by 30 lM AH7614 and by cell washing and (c) LPA also induced a strong calcium response that did not block TUG-891 action (Fig. S1 ). The ability of TUG-891 to desensitize LPA 1 action is consistent with previously published data [20, 21] . It has been previously observed that conventional PKC isoform activation blocks LPA 1 -mediated effects [26, 42] . Therefore, we tested the PKC inhibitor, bisindolylmaleimide I [45] , on DHA-mediated LPA 1 desensitization; this inhibitor was without effect, ruling out a role of PKC activation in this effect (representative calcium tracings are presented in Fig. S2 ).
It is well-known that LPA can induce ERK 1/2 phosphorylation in a time-dependent fashion. Therefore, we tested whether pretreatment with DHA could inhibit MAP kinase activation. DHA by itself induced a rapid and transient 2 to 3-fold increase in ERK 1/2 phosphorylation (Fig. 2, panel A) . Similarly, LPA induced a 2 to 3-fold increase in ERK 1/2 phosphorylation at 2 and 5 min, returning to baseline levels at 15 and 30 min (Fig. 2, panel B) . Cell pre-treatment with DHA markedly reduced subsequent LPA-induced ERK 1/2 phosphorylation (Fig. 2, panel B) , in agreement with observations in cells endogenously expressing these receptors [21] . Similar crosstalk has been observed with other G protein-coupled receptors, e.g., b 2 -adrenoceptor activation blocks oxytocin receptormediated ERK activation [46] .
Receptor phosphorylation appears to be an early step in GPCR desensitization/ signaling switch and internalization [22, [47] [48] [49] . In order to test whether, during the FFA4-mediated LPA 1 -desensitization, this event could play a role, phosphorylation of FFA4 and LPA 1 was evaluated in the same cell samples. In agreement with previous observations [31, 34, 50, 51] , the FFA4 phosphorylation state increased in response to DHA; this action reached its maximum response at 5 min and returned toward baseline levels at later times (Fig. 3, panel A) . Interestingly, LPA 1 was also phosphorylated in response to FFA4 activation with similar kinetics (Fig. 3, panel B) . The effect of LPA on the phosphorylation of these receptors was also examined. Stimulation with 1 lM LPA for 5 min increased LPA 1 phosphorylation (Fig. 3, panel D) , in agreement with previous reports [26, 41] but no increase in FFA4 phosphorylation was observed under these conditions (Fig. 3, panel C) . The possibility that the antibodies used in the immunoprecipitation studies could crossreact was considered, but such possibility was discarded experimentally (Fig. S3) . Receptor internalization was studied by confocal imaging. Receptor colocalization at the plasma membrane was evidenced in the merged images (Fig. 4) ; some fluorescence was also detected in intracellular vesicles but little colocalization was observed (Fig. 4) . As previously noted [31, 34] , agonist activation induced FFA4 internalization (Fig. 4 , panels A and C). DHAinduced internalization was significant at 5 min, reached its maximum at 30 min, and FFA4-mCherry intracellular fluorescence markedly decreased at 60 min, apparently increasing at the plasma membrane, as also evidenced in the merged image (Fig. 4) . These data suggest that FFA4 internalization took place during the first 30 min of agonist activation and that this was followed by recycling to the plasma membrane. Interestingly, localization of LPA 1 , mainly at the plasma membrane under baseline conditions, did not change in response to DHA (Fig. 4) , indicating that receptor co-internalization did not play an important role in LPA 1 heterologous desensitization. No increase in receptor colocalization in intracellular vesicles was detected during these studies. In order to obtain further information, an area of the cells (2.5 lm 9 2.5 lm), in which vesicles accumulate, was selected and amplified (Fig. 4 , panel C, last columns); as can be observed, intracellular vesicles contain FFA4-mCherry. To further explore the receptor's crosstalk the effect of LPA on LPA 1 and FFA4 where not shown, they are within the symbol) of 24 different images in each case (four independent experiments using different cell preparations, six images were obtained from each experiment). Data for FFA4 and LPA 1 ; *P < 0.05 vs. baseline; **P < 0.001 vs. baseline. In Panel C representative images of cells observed in the different channels (red, green and merge) are presented, using as agonists: DHA (left images) or LPA (right images). In the merge images an intracellular section (2.5 lm 9 2.5 lm) with vesicle accumulation was selected (marked) and amplified as shown in the last columns. Bars, 10 lm.
internalization was studied in these cells. LPA 1 agonist-activation induced receptor internalization that was significant at 15 min, continued to increase and reached a plateau at 30-60 min (Fig. 4 , panels B and C). Interestingly, LPA also induced FFA4 internalization and with similar kinetics (Fig. 4, panels B and C) . This was surprising because LPA induced no clear increase in FFA4 phosphorylation. However, phosphorylation-independent receptor internalization has been observed [52, 53] . Intracellular amplification confirmed that LPA induced internalization of both receptors and, additionally, that these receptors accumulate in three types of vesicles containing the following: a) mainly FFA4 receptors (red), b) mainly LPA 1 receptors (green) or both receptors (yellow). These data suggest the involvement of different internalization processes and that these receptors might move to different cellular locations (i. e., different endosomal compartments). There is already published information indicating that GPCRs might internalize into different compartments under different conditions (see, for example [54, 55] and references therein). Hetero-dimerization of GPCRs has been observed with increasing frequency and there is evidence that these receptor-receptor interactions can modify their signaling, pharmacological properties and cellular localization [27, 28] . To test whether the activation of FFA4 induces heterodimerization with LPA 1 , FRET experiments were conducted. FRET signal was detected in the absence of stimulation; although a weak signal was observed, this does not allow us to discard that some baseline interaction between FFA4 and LPA 1 receptors might exist. Stimulation with DHA induced a time-dependent increase in FRET signal, with a maximal signal at 15 min, returning towards baseline afterward (Fig. 5, panels A and B) . It is interesting to emphasize that during the times of maximal FRET levels, FFA4 (but not LPA 1 ) was significantly internalized; i.e., the majority of LPA 1 receptors remained in the plasma membrane after DHA stimulation whereas a significant fraction of FFA4 receptors internalized and other fraction continued with plasma membrane localization. Analysis of the FRET images showed that the FRET signal was mainly emitted from the plasma membrane and structures with close proximity to it; however, some FRET was also emitted from intracellular structures. Considering the time-courses of functional desensitization (calcium response, nearly immediate), rapid co-internalization of both receptors does not appear to be a key factor in LPA 1 desensitization, but some FFA4-LPA 1 interaction did take place as a relatively late event (i.e., > 10 min of agonist action) during the process. Agonist LPA 1 activation did not induce any clear FRET emission. This was surprising since LPA induced internalization of both FFA4 and LPA 1 receptors and even colocalization was detected in some of the intracellular vesicles (Fig. 4) . It should be borne in mind that in order to observe FRET, fluorophores should be at a distance in the range of 1-10 nm (i.e., in very close proximity, frequently considered as an index of molecular interaction) [56] . In contrast, fluorescent co-localization depends on the limit of optical resolution, which is within the range of 300 nm in standard laser scanning microscopy [57] .
In order to confirm the FRET results, co-immunoprecipitation experiments were performed. As in the case of the FRET experiments, baseline co-immunoprecipitation was detected, the latter increased after short times of stimulation (5 and 15 min) and at longer times (30 and 60 min) it returned to baseline levels (Fig. 6) .
Our data indicate that FFA4 activation leads to LPA 1 functional desensitization (calcium signaling and ERK 1/2 phosphorylation) and that it is associated to phosphorylation of both FFA4 and LPA 1 ; only the former receptor is actively internalized. Therefore, the LPA 1 desensitization process appears to take place at the cell plasma membrane, i.e., seems to be receptor internalization-independent. The rapid reversibility of this desensitization (through ligand washing) also supports this possibility. Interestingly, peak FFA4-LPA 1 interaction (FRET) occurred after receptor phosphorylation had reached its maximum and LPA 1 desensitization had already taken place (calcium signaling). In addition, the data indicate that activation of LPA 1 receptors induces LPA 1 and FFA4 internalization, but that there is no immediate desensitization of FFA4 receptors. Our findings illustrate how the crosstalk of two GPCRs crosstalk lead to different outcomes in both signaling and receptor localization. Receptor crosstalk and desensitization involve different molecular and cellular processes with particular spatio-temporal dynamics and in which the cellular context is likely to be important. For example, the marked internalization of both LPA 1 and FFA4 could be relevant after relatively long-term activation with LPA, particularly in cells in which receptor densities could be ratelimiting for the responses. The present data provide additional information on the molecular process involved in the crosstalk between these receptors and illustrate the need for different experimental approaches to obtain further insights on the participating molecular and cellular events.
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